Single-cell RNA sequencing analyses have shown that MDA5+ DM patients has a unique adaptive immune landscape characterized by hyperactivation of type I IFN signaling and aberrant metabolic reprogramming. This evidence concerns the gene IFIH1 and dermatomyositis.